Comparing the Benefit of Duplex Ultrasound Surveillance Following Both Infrainguinal Bypass Surgery and Stenting for Femoro-Popliteal Disease.


Journal

Vascular and endovascular surgery
ISSN: 1938-9116
Titre abrégé: Vasc Endovascular Surg
Pays: United States
ID NLM: 101136421

Informations de publication

Date de publication:
Jan 2023
Historique:
pubmed: 17 8 2022
medline: 23 11 2022
entrez: 16 8 2022
Statut: ppublish

Résumé

Duplex ultrasound surveillance (DUS) is commonly used following infrainguinal vein bypass. The role of DUS following endovascular revascularisation is as yet unclear. This study focuses on the role of DUS in a contemporary group of patients undergoing infrainguinal bypass or stent insertion. All patients undergoing either an infrainguinal vein graft bypass or stent insertion into the femoro-popliteal segment (November 2014 - January 2017) were identified. Patients were followed up for 2 years. Data on entry into DUS, pre-operative characteristics, adjunctive pharmacotherapy and reintervention were collated. The primary outcomes were major lower limb amputation and mortality at 2 years post revascularisation. One hundred and thirty-five patients underwent infrainguinal vein bypass and 100 patients underwent stent insertion. 107 patients in the bypass cohort and 58 patients in the stent cohort entered DUS. For the bypass cohort, entering DUS was associated with a lower mortality rate ( DUS was associated with improved survival rates in patients undergoing lower limb bypass but had no benefit in those patients undergoing stent insertion. The role of DUS following stent insertion in the femoropopliteal segment needs to be better defined.

Identifiants

pubmed: 35972881
doi: 10.1177/15385744221119627
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

11-18

Auteurs

Than Dar (T)

University of Cambridge, Cambridge, UK.

Lanxin Li (L)

University of Cambridge, Cambridge, UK.

Melvinder Basra (M)

Cambridge Vascular Unit, 4472Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Stephen Crockett (S)

Cambridge Vascular Unit, 4472Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Mohammed M Chowdhury (MM)

Cambridge Vascular Unit, 4472Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Lukasz Piotr Zielinski (LP)

Cambridge Vascular Unit, 4472Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Graeme K Ambler (GK)

Department of Vascular Surgery, Bristol Royal Infirmary, UK.

Patrick A Coughlin (PA)

Cambridge Vascular Unit, 4472Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH